Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0UK7K
|
|||
Drug Name |
PMID27454349-Compound-91
|
|||
Drug Type |
Small molecular drug
|
|||
Company |
Wisconsin-Alumni-Research-Foundation
|
|||
Structure |
Download2D MOL |
|||
Formula |
C27H44O3
|
|||
Canonical SMILES |
CC(CCCC(C)(C)O)C1CCC2C1(CCCC2=CC=C3CC(C(=C)C(C3)O)O)C
|
|||
InChI |
1S/C27H44O3/c1-18(8-6-14-26(3,4)30)22-12-13-23-21(9-7-15-27(22,23)5)11-10-20-16-24(28)19(2)25(29)17-20/h10-11,18,22-25,28-30H,2,6-9,12-17H2,1,3-5H3/b21-11+/t18-,22?,23-,24+,25+,27+/m0/s1
|
|||
InChIKey |
UHMPCVGLSKFXHR-NFZXMVPNSA-N
|
|||
CAS Number |
CAS 213250-70-5
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Vitamin D3 receptor (VDR) | Target Info | Agonist | [1] |
Target's Patent Info | Vitamin D3 receptor (VDR) | Target's Patent Info | [1] | |
KEGG Pathway | Endocrine and other factor-regulated calcium reabsorption | |||
Mineral absorption | ||||
Tuberculosis | ||||
NetPath Pathway | IL4 Signaling Pathway | |||
Panther Pathway | Vitamin D metabolism and pathway | |||
Pathway Interaction Database | Regulation of nuclear SMAD2/3 signaling | |||
Direct p53 effectors | ||||
RXR and RAR heterodimerization with other nuclear receptor | ||||
Retinoic acid receptors-mediated signaling | ||||
Validated transcriptional targets of deltaNp63 isoforms | ||||
Validated transcriptional targets of TAp63 isoforms | ||||
Reactome | Nuclear Receptor transcription pathway | |||
WikiPathways | Ovarian Infertility Genes | |||
Nuclear Receptors in Lipid Metabolism and Toxicity | ||||
Nuclear Receptors Meta-Pathway | ||||
Vitamin D Receptor Pathway | ||||
Drug Induction of Bile Acid Pathway | ||||
Nuclear Receptors | ||||
Vitamin D Metabolism |
References | Top | |||
---|---|---|---|---|
REF 1 | Vitamin D receptor 2016: novel ligands and structural insights.Expert Opin Ther Pat. 2016 Nov;26(11):1291-1306. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.